🇺🇸 FDA
Patent

US 8901095

Selective inhibition of polyglutamine protein expression

granted A61KA61K47/645A61P

Quick answer

US patent 8901095 (Selective inhibition of polyglutamine protein expression) held by The Board of Regents of the University of Texas System expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K47/645, A61P, A61P25/00, A61P25/14